This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Scientists had published legitimate research findings showing that cannabis compounds had actually slowed tumor growth in mice. He developed a concentrated oil from the cannabis plant and decided to try it on himself. He developed a concentrated oil from the cannabis plant and decided to try it on himself. Not Rick Simpson.
In the 1990s cannabis based researchers discovered that we all possess this whole-body, internal system designed to work with the compounds of medical marijuana and CBD. The growers didn’t just stumble onto thisthey carefully developed it with one goal in mind: maximum therapeutic benefit with zero psychoactive effects.
Researchers have steadily advanced the field of psychedelic-assisted therapy over the last decade or two. This passage also spurred the development of an eagerly anticipated psychedelic-assisted therapy industry, now ready to see its very first patients very soon. How Does Colorado’s Natural Medicine Program Compare to Oregon’s?
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
In the previous Congress, The Ending Federal Marijuana Prohibition Act became the first bill in American history to end the federal policy of criminalization that earned bipartisan support. To date, these statewide regulatory programs are operating largely as voters and politicians intended.
California is looking to bolster its struggling cannabis market, Australia made psychedelic history, and Pennsylvania inched toward recreational legalization. The Supervisor sees a future where the bill makes dispensaries more enjoyable spaces and in turn allows for further economic developments. Let’s dive into this week’s cannanews.
Throughout history, creative minds have embraced cannabis. Now, a study from researchers at the University of Michigan has concluded that it may also be a favorite among creative geniuses of today—specifically, the software developers that make all the magic happen behind the scenes. Cannabis and Programming.
This article explores the history of medical marijuana in Ohio, analyzes the changing attitudes and acceptance, and delves into the impact of stigma on its journey to legalization. The journey begins with early debates around the medicinal use of cannabis, leading to the eventual establishment of the state’s medical marijuana program.
Hartin served as Director of Compliance and Enforcement for the Oklahoma Medical Marijuana Authority, where she oversaw compliance for the state’s medical cannabis program and played an integral role in the OMMA’s legislative and regulatory processes.
Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.
But today, thanks to a combination of changing laws and attitudes and a building consensus of scientific research, there’s another, perhaps unexpected option – ketamine. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” ” 8 9.
Session 1: The Shulgin’s Pioneering Psychedelic Research (12:00 PM-2:00 PM PDT). Moderator: Bob Jesse – researcher, engineer, convener of the Council on Spiritual Practices. Dr. Paul Daley – Chief Science Officer and Chemist, Alexander Shulgin Research Institute. Join Session 2. Sunday, June 27, 2021. Join Session 3.
Reporting to a Program Specialist 3 (Cannabis), the Program Specialist 2 (Cannabis) positions will be responsible for overseeing and participating in inspecting, auditing, and performing a full range of compliance duties for the region assigned (Albany/Buffalo/NYC). Duties Description. Perform full range of supervisory functions.
Some states have broadly permissive MMJ laws, while others have more restrictive programs. Alaska: Alaska has a robust MMJ program, allowing for the use of medical marijuana for qualifying conditions. Arizona: Arizona has a well-established MMJ program that covers various qualifying conditions, with strict possession limits.
The Center for Psychedelic Drug Research and Education (CPDRE) was approved by the Ohio State College of Social Work faculty in January, and its director, Assistant Professor of Social Work Alan Davis , officially took the helm in March. Initial goals of the center are focused on research and educational initiatives. Jason Slot.
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments. RHO Phyto is the first medical formulary of advanced “Cannabis 2.0”
However, if you read about the history of cannabis in the region, you will know that they used the plant for textile purposes. At the moment, Japan does not have any medical cannabis program for their patients. New researches and studies about the clinical use of cannabis in Japan are setting the trend all over the country.
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0”
Scientists stumbled upon a solution to California’s HLVd problem, Australia made psychedelic history, and a North Carolina senator is fighting for medical cannabis. Plants hit with HLVd show issues like yellow leaves, abnormal branching, stunted development, and nearly 50% loss in cannabinoid production. Do you think Sen.
Seaweed project part of company’s $140M circular economy research, developmentprogram. After initial testing, the company also is researching seaweed’s potential role as a barrier coating, replacing problem plastics and petroleum-based packaging used to protect many foodstuffs.
The board will work on projects like designing the training program for psychedelic facilitators, tracking psychedelic policy development, studying ongoing science related to psilocybin, and making recommendations to lawmakers regarding the bill. Arizona is making progressive steps forward when it comes to psychedelic research.
By joining forces, PSI will be able to leverage its size and experience to help expand research and development and testing services. California is a critical market in the United States, with a long history of leading innovation and elevating the conversation around national legalization,” said Ben Rosman, J.D.,
( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed what it believes to be the largest legal natural psilocybin harvest in Canadian history. Optimi Chief Operations Officer, Bryan Safarik, says the yield exceeded expectations in terms of quality and quantity. “By Penis Envy.
The current public policies in local and state cannabis ordinance and equity programs may enhance racial disparities if they follow the pattern of exclusion and criminalization that encompass past policies promoted as beneficial to African Americans but uphold racial capitalistic practices. Central Research Question. Recommendations.
Avicanna”), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. The Branded Products include Avicanna’s proprietary cannabinoid topical formulations developed through years of extensive research by Avicanna’s team of scientists.
(TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis, is pleased to announce that it has been granted a Research License by Health Canada. We are all in on cultivating the best cannabis on earth and for the earth.
Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.
The South American country has a rich cultural history of cannabis use, with indigenous communities using it for medicinal, spiritual, and cultural practices for centuries. The Ministry of Health oversees the medical cannabis program, ensuring proper regulations and quality control. Is it legal to grow weed in Peru?
VANCOUVER — Doctors with opposing views on whether medical marijuana should be prescribed for various conditions agree on one thing: their profession is ill-prepared to deal with patients asking for a drug that lacks adequate clinical research. “It’s a tough situation. “It’s a tough situation.
TRC Healthcare (TRC) has launched a new training program to help pharmacists deliver better healthcare for patients who use cannabis products. The online program, known as RxAdvanced: Guide to Cannabis , gives pharmacists a foundational knowledge of cannabis that strengthens their role as stewards of public health. “As Press Release.
Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.
Results from a variety of research studies in recent years repeatedly show that a customer relationship management (CRM) strategy can have a significant positive effect on sales, marketing, customer service, and more. . For example, Nucleus Research discovered that the average return on a company’s CRM investment is $8.71
– Company’s safeCircle™ Testing Program to Monitor for COVID-19 Among On-Campus Unvaccinated Populations –. Under the Contract, ADCL will deploy safeCircle™, its high-throughput, pooled COVID-19 testing program, to provide cost-effective COVID-19 testing. STONY BROOK, N.Y.–(BUSINESS
On June 30th, the Petrie-Flom Center announced the launch of a three-year research initiative , the Project on Psychedelics Law and Regulation (POPLAR) , which is supported by a generous grant from the Saisei Foundation. POPLAR will publish original law and policy research. What barriers exist to conducting psychedelics research?
One crop that kept coming up was cannabis — which includes hemp and marijuana — that has some family history for Lee. “I We, as a university, need to be the ones to start developing and establishing some research for the younger generation.”. Source: [link].
Register for our new digital learning program. Dear Sean, MAPS is excited to announce the launch of Psychedelic Fundamentals , an online psychedelic education program which provides people with accurate, evidence-based information about psychedelics. Psychedelic Fundamentals , An Online Education Curriculum. Register Now.
The LinearDNA platform has utility in the nucleic acid-based in vitro diagnostics and preclinical nucleic acid-based drug development and manufacturing market. Hurry, 917-733-5573, sanjay.hurry@adnas.com Program Contact: Mike Munzer, 631-240-8814, mike.munzer@adnas.com Web: www.adnas.com Twitter: @APDN.
a manufacturer of LinearDNA™ via PCR for nucleic acid therapeutics and diagnostics, today announced the receipt of repeat orders from diagnostic customers and a first Contract Research Organization (CRO) order from a new biotherapeutic customer, a federally funded research and development laboratory focused on cancer research.
Pavel Otáhal, contributing author and Head of the Gene Immunotherapy Research Department at ÚHKT, stated, “Our study compares the manufacture of CAR19 T-cells via PCR-made transposon DNA (LinearDNA) with mRNA encoding of the transposase against a conventional plasmid approach. Dr. James A. About LineaRx, Inc.,
She is a mother, activist, artist and NADA acupuncture practitioner focused on developing substance abuse and post-trauma treatment programs for communities in need. It’s shocking, and what’s more, is that the authorities feel justified because it is illegal and don’t care what evidence is out there about its history here.
During his career, McKay has run large organizations with a focus on business development, strategic partnerships, and consumer engagement. He has developed partnerships for companies like Costco, Fisher Media, and the biotechnology space. Andrea Brooks is a cannabis advocate, public speaker, and former global development consultant.
In the article, titled Association Between Marijuana Use and Risk of Cancer, A Systematic Review and Meta-Analysis , researchers looked at 25 studies dating back to 1973, with the goal of “assessing marijuana use and the risk for developing lung, head and neck, urogenital, and other cancers.” Of the more than 1.7
According to Dr. Sue Sisley, President of the Scottsdale Research Institute and longtime cannabis researcher, this new study is sorely needed in the community. Veterans are demanding objective cannabis drug developmentresearch, and the state of Michigan is fulfilling our collective obligation to our beloved Veteran community.”.
She is a mother, activist, artist and NADA acupuncture practitioner focused on developing substance abuse and post-trauma treatment programs for communities in need. It’s shocking, and what’s more, is that the authorities feel justified because it is illegal and don’t care what evidence is out there about its history here.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content